Cooley Event - Mezzanine Debt, Hybrid Royalty and Royalty Purchase Financing for Life Sciences and Medical Device Companies

Thursday, May 15 2014
8:00 am – 10:00 am

Location: Cooley, 500 Boylston Street, 14th floor, Boston, MA

Creative debt financing has never been more available or varied than it is today. Mezzanine debt, hybrid royalty and royalty purchase financing alternatives are viable funding options and sometimes have compellingly attractive terms. Join us at this invitation-only gathering for senior life sciences and medical device company executives as industry experts will share their different perspectives.

Panelists:

  • David CarterPrincipal, Capital Royalty
  • David SabowManaging Director and Head of Life Sciences, Silicon Valley Bank
  • Parag ShahSenior Managing Director and Group Head, Life Sciences, Hercules Technology Growth Capital

Moderator:

REGISTRATION REQUIRED. This event is by invitation-only and subject to approval by Cooley. There is no charge to attend. For more information, please contact Ilana Brand.

Click here to register.

Discussion topics include:

  • Company prospects and performance metrics for the various funding alternatives
  • Pricing levels and options
  • Term loan features with longer maturities, non-amortizing periods, and PIK periods
  • Tranching of draws and milestone requirements for availability
  • When warrants are required and the terms needed
  • When and how to use an investment advisor to solicit lenders

Share MassBio

 

BioProcess

EvaluatePharma 

MassBio